{
    "clinical_study": {
        "@rank": "102554", 
        "arm_group": [
            {
                "arm_group_label": "Investigational Product", 
                "arm_group_type": "Experimental", 
                "description": "Omega-3 fatty acids in the form of triglycerides"
            }, 
            {
                "arm_group_label": "Comparator Product 1", 
                "arm_group_type": "Active Comparator", 
                "description": "Omega-3 fatty acids in the form of ethyl esters."
            }, 
            {
                "arm_group_label": "Comparator Product 2", 
                "arm_group_type": "Active Comparator", 
                "description": "Omega-3 fatty acids in the form of phospholipids from krill oil."
            }, 
            {
                "arm_group_label": "Comparator Product 3", 
                "arm_group_type": "Active Comparator", 
                "description": "Omega-3 fatty acids from salmon oil."
            }
        ], 
        "brief_summary": {
            "textblock": "Supplementation with omega-3 fatty acids has been extensively researched and is known to\n      provide healthful benefits for patients with a diversity of conditions and diseases.  Not\n      all omega-3 supplements are created equally however; some sources of omega-3 fatty acids are\n      superior to others due to a greater bioavailability of omega-3 fatty acids than others,\n      differences in source material, and processing techniques.\n\n      The purpose of this study is to determine which marketed omega-3 product provided the\n      greatest effect, as measured against its' label claim and recommended dosage."
        }, 
        "brief_title": "A Marketing-oriented Study to Evaluate the Comparative Bioavailability of Omega-3 Fatty Acids From Four Different Natural Health Products", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Comparative Bioavailability", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Participant is fluent in English\n\n          -  Participant understands the study requirements and is willing to comply with the\n             protocol\n\n          -  Participant is willing to provide written informed consent\n\n          -  Participant is 18 years of age or older\n\n        Exclusion Criteria:\n\n          -  Unwilling or unable to provide written consent\n\n          -  Participant has taken omega-3 supplements in the last 3 months\n\n          -  Participants consumes fish on a regular basis (more than 1 serving per week)\n\n          -  Females who are pregnant or breastfeeding\n\n          -  Participant has an allergy to fish or seafood\n\n          -  Participant has been diagnosed with any medical illness or conditions\n\n          -  Participant has a history of drug dependence or substance abuse (excluding nicotine)\n\n          -  Participant is taking cholesterol or triglyceride lowering medications or supplements\n             (statins, niacin, carnitine, fibrates)\n\n          -  Individual has difficulty giving multiple blood samples"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "35", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01960660", 
            "org_study_id": "12.0216", 
            "secondary_id": "12-03-001"
        }, 
        "intervention": {
            "arm_group_label": [
                "Investigational Product", 
                "Comparator Product 1", 
                "Comparator Product 2", 
                "Comparator Product 3"
            ], 
            "intervention_name": "Omega-3 Fatty Acids", 
            "intervention_type": "Dietary Supplement", 
            "other_name": [
                "EPA: Eicosapentaenoic acid (20:5(n-3))", 
                "DHA: Docosahexaenoic acid (22:6(n-3))"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Fish Oil", 
            "EPA", 
            "DHA", 
            "Omega-Score", 
            "Lipemic Index", 
            "ethyl esters", 
            "triglycerides", 
            "phospholipids"
        ], 
        "lastchanged_date": "October 9, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Guelph", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "N1G0B4"
                }, 
                "name": "Nutrasource Diagnostics Inc"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Marketing-oriented Study to Evaluate the Comparative Bioavailability of Omega-3 Fatty Acids From Four Different Natural Health Products", 
        "overall_official": [
            {
                "affiliation": "Nutrasource Diagnostics", 
                "last_name": "Maggie D Laidlaw, Ph.D", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Nutrasource Diagnostics", 
                "last_name": "Carla Cockerline, M.Sc", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The Omega ScoreTM is a measurement of the levels of the Omega-3 Fatty Acids in a blood sample. The summed amounts of these Omega-3 Fatty Acids (EPA+DPA+DHA) as a % of the total fatty acids represents the Omega ScoreTM in whole blood.", 
            "measure": "Omega-Score", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline in Omega-Score at 28 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01960660"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The Lipemic Index\u2122 is the post-prandial rise in TG levels over a 5-hour period, following the consumption drink containing a measured amount of fat, carbohydrate and protein.", 
            "measure": "Lipemic IndexTM", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline in Lipemic Index at 28 days"
        }, 
        "source": "Nutrasource Diagnostics Inc.", 
        "sponsors": {
            "collaborator": {
                "agency": "Nordic Naturals", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Nutrasource Diagnostics Inc.", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}